Press Releases
SAN DIEGO, Oct. 1, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis) for the treatment of various cancers including prostate, colorectal and leukemia, today announced the presentation of its Phase
Read more...1 October 2019
IRVINE, Calif., Oct. 1, 2019 /PRNewswire/ -- Acorns, the country's fastest-growing financial wellness system with 6.2 million users, has announced a new partnership with Chevron to support local
Read more...1 October 2019
ANDOVER, Mass., Oct. 1, 2019 /PRNewswire/ -- Cambridge University Hospitals NHS Foundation Trust (CUH), one of the largest and best-known trusts in the United Kingdom, has reported considerable cost and time savings with its medical device integration initiative.
Read more...1 October 2019
CAMPBELL, Calif., Oct. 1, 2019 /PRNewswire/ -- VivaLNK, a leading provider of connected healthcare solutions, is improving clinical trials with continuomics by using wearable medical sensors for remo
Read more...1 October 2019
LISLE, Ill, Oct. 1, 2019 /PRNewswire/ -- Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure (HF), today announced the expansion of its
Read more...HENDERSON, Nev., Oct. 1, 2019 /PRNewswire/ -- Dalrada Precision, a wholly-owned subsidiary of Dalrada Financial Corp. (OTC Pink: DFCO), continued its advancement in the pharmaceutical and healthcare spaces by announcing it had filed a patent for its specialized extraction machine.Filing the patent and the resulting registration represents the company's tremen
Read more...1 October 2019
LONG BEACH, Calif., Oct. 1, 2019 /PRNewswire/ -- SCAN Health Plan® today announced its 2020 health plan benefits in Northern California and
Read more...1 October 2019
LONG BEACH, Calif., Oct. 1, 2019 /PRNewswire/ -- SCAN Health Plan®, today announced its 2020 health plan benefits for Southern California, which
Read more...1 October 2019
SOUTH SAN FRANCISCO, Calif., Oct. 1, 2019 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) and Crossroads of Southern Nevada ("Crossroads") rehabilitation facility today announced that Crossroads has healthcare providers who are specially trained in the insertion and removal of Probuphine® (buprenorphine
Read more...1 October 2019
SAN FRANCISCO, Oct. 1, 2019 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today several promotions on its executive leadership team: Jonathan Zalevsky, Ph.D. has been promoted to Chief Research & Development Officer Gil M. Labrucherie has been prom
Read more...